Basic Information
Octanate 250IU Powder and Solvent for Solution for Injection
INJECTION, POWDER, FOR SOLUTION
Regulatory Information
SIN12512P
February 6, 2004
Prescription Only
Therapeutic
INTRAVENOUS
August 10, 2023
June 3, 2025
XB02BD02
Company Information
WELLCHEM PHARMACEUTICALS PTE LTD
WELLCHEM PHARMACEUTICALS PTE LTD
Active Ingredients
COAGULATION FACTOR VIII (HUMAN)
Strength: 250 iu/5 ml vial
Detailed Information
Contraindications
**4.3 Contra-indications** Absolute contra-indication: - known allergic reactions to constituents in the preparation.
Indication Information
**4.1 Therapeutic indications** Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).